Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim
New twice-a-day dosing regimen allows for daily immune system supportCompany intends to create a monthly subscription model for this new...
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency